International Society of Hypertension

ISH - Hero Image 1ISH - Hero Image 2ISH - Hero Image 3ISH - Hero Image 6ISH - Hero Image 8ISH - Hero Image 9ISH - Hero Image 14ISH - Hero Image 15ISH - Hero Image 16ISH - Hero Image 17ISH - Hero Image 18ISH - Hero Image 19ISH - Hero Image 20ISH - Hero Image 21ISH - Hero Image 22ISH - Hero Image 23

Our Officers & Committees

The society is comprised of a range of committees. These are charged with various responsibilities, but ultimately with the same aim of ensuring that it continues to grow and strengthen as the world's premiere blood pressure society, whilst ensuring that youth and developing countries are reflected where possible.

Professor Neil Poulter (International Centre for Circulatory Health (ICCH), London, UK) commenced his ISH presidency on 28th September during the Hypertension Seoul Meeting (26th Scientific Meeting of the International Society of Hypertension).

Council

The Council is responsible for furthering the aspirations and activities of the ISH, ensuring its efficient running and controlling its property and funds. ISH Council members are also Trustees of the Charity.

The Executive of the Council (Executive Committee) takes a critical role in helping the Council set policies and goals for the Society, and is delegated to act for the Council in the day-to-day activities of the Society, such as providing direction to the ISH Secretariat, of making the necessary arrangements for the next ISH Biennial Scientific and General Meetings and other scientific activities, of overseeing the work of all committees and working parties, and for giving final consideration for all nominations for membership.

Executive of Council

  • Alta Schutte profile image

    Alta Schutte President

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Fadi Charchar profile image

    Fadi Charchar Vice President | Chair, New Investigator and Mentorship Committee

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Thomas Unger profile image

    Thomas Unger Secretary

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

  • Markus Schlaich profile image

    Markus Schlaich Treasurer | Chair, Corporate Liaison Committee | Co-Chair, North Asia, South-East Asia and Oceania Regional Advisory Group

    Australia

    more

    I am the Dobney Chair in Clinical Research at the University of Western Australia, based at the Royal Perth Hospital. As a clinician-scientist and renal physician I have specific interest in hypertension associated with chronic kidney disease and the role of the sympathetic nervous system in this scenario. My major aim is to translate evidence from mechanistic studies into clinical practice to improve outcomes for patients with hypertension and associated co-morbidities.

  • Richard Wainford profile image

    Richard Wainford Officer at Large | Chair, Membership Committee | AHA Liaison Officer

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

  • Neil Poulter profile image

    Neil Poulter Immediate Past President | Chair, International Forum | May Measurement Month Lead

    UK

    more

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Muscha (Ulrike) Steckelings profile image

    Muscha (Ulrike) Steckelings Chair, ISH Women in Hypertension Committee

    Denmark

    more

    My research interests lie in the protective arm of the renin angiotensin system, in particular the angiotensin AT2-receptor and the receptor MAS, spanning from the basic biology of these receptors over pre-clinical studies to test their therapeutic efficacy in cardiovascular (e.g. heart failure, hypertensive and diabetic end organ damage, stroke) and other diseases to the involvement in the development of AT2-recepor agonists for future clinical use.

  • Dylan Burger profile image

    Dylan Burger Chair, Communications Committee

    Canada

    more

    My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

  • Claudio Borghi profile image

    Claudio Borghi Chair, Research, Science and Education Committee | ESH Liaison Officer

    Italy

    more

    My main areas of interest are the hypertension and related cardiovascular risk factors and drug therapy of hypertensive disease. In particular I am very interested in the interactions between hypertensive disease and metabolic risk factors paying a special attention to epidemiology, pathophysiology and drug treatment including the options supporting the use of different preventive approaches in patients with complex CV risk profile. I am also involved in the development of a nutraceutical approach to the management of hypertension and related risk factors.

Ordinary Members of the Council

  • Rafael Castillo profile image

    Rafael Castillo

    Philippines

    more

    As a senior clinical cardiologist at the Manila Doctor’s Hospital and a pioneering faculty member at the Adventist University College of Medicine, I’m part of a group involved in clinical trials evaluating drug and non-drug interventions in the management of high-risk hypertensive patients with various comorbidities. I’m a past president of the Asian Pacific Society of Hypertension, Philippine Heart Association/Philippine College of Cardiology, Philippine Society of Hypertension; and past chair of the Philippine Specialty Board of Adult Cardiology.

  • Myeong-Chan Cho profile image

    Myeong-Chan Cho

    South Korea

  • Sadayoshi Ito profile image

    Sadayoshi Ito Deputy Chair, Corporate Liaison Committee

    Japan

    more

    My areas of research are the renin-angiotensin-aldosterone system and glomerular hemodynamics in basic research, and hemodynamics in hypertension, secondary hypertension and chronic kidney disease in clinical research.

  • Hiroshi Itoh profile image

    Hiroshi Itoh Kyoto 2022 Liaison Officer

    Japan

  • Nadia Khan profile image

    Nadia Khan Co-Chair, Americas Regional Advisory Group

    Canada

    more

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

  • Yoshihiro Kokubo profile image

    Yoshihiro Kokubo Co-Chair, North Asia, South-East Asia and Oceania Regional Advisory Group | APSH Liaison Officer

    Japan

    more

    I am a chief doctor in the National Cerebral and Cardiovascular Center, Japan. My specialty is preventive medicine and epidemiology, especially related to hypertension and kidney dysfunction. I contribute to many international societies in variety of capacities and editorial board activities in the areas of hypertension, stroke, and preventive medicine.

  • Dorairaj Prabhakaran profile image

    Dorairaj Prabhakaran Chair, South and West Asia and Middle East Regional Advisory Group

    India

    more

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence, Centre for Cardio-metabolic Risk Reduction in South Asia (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Agustin Ramirez profile image

    Agustin Ramirez Co-Chair, Americas Regional Advisory Group | LASH Liaison Officer

    Argentina

    more

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • George Stergiou profile image

    George Stergiou Chair, Awards Committee

    Greece

  • Maciej Tomaszewski profile image

    Maciej Tomaszewski

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Bryan Williams profile image

    Bryan Williams ESC Hypertension Council Liaison Officer

    UK

Ex-Officio Members of the Council

  • Daniel Lackland profile image

    Daniel Lackland WHL Representative

    USA

    more

    I am the Director of Translational Neuroscience and Population Studies with a focus on implementation science and precision medicine. I continue to serve on clinical practice guidelines panels with research interest involving the population risk assessment of cardiovascular disease, stroke and hypertension. As current President of the World Hypertension League, I have directed effort and focus to the global implementation of prevention and control strategies for high risk populations throughout the world.

  • Lewis Landsberg profile image

    Lewis Landsberg Board of Management of the Journal of Hypertension

    USA

    more

    Areas of interest in relation to blood pressure:

    • Sympathetic nervous system
    • Obesity-related hypertension
    • The metabolic syndrome
  • Lars H. Lindholm profile image

    Lars H. Lindholm Hypertension News

    Sweden

    more

    I have been President of the Swedish Society of Hypertension (1989-92), Secretary (the first) of the European Society of Hypertension, ESH (1989-97) , and President of the ISH (2006-8). Since 2009, I have been an honorary member of the British Society of Hypertension.

    My interest in hypertension and its risks started in the late 1970s and I defended my doctoral thesis on this topic in 1994. Since 1998, I am Professor and chairman at the Department of Public Health and Clinical Medicine at Umeå University, Sweden.

  • Trefor Morgan profile image

    Trefor Morgan APSH Representative

    Australia

    more

    I am a Physiologist Clinician with experimental, and clinical involvement in Salt and water Metabolism and the renin angiotensin system. Trained as a nephrologist and cardiologist.

    Secretary General of the Asian Pacific Society of Hypertension.

  • Enrico Agabiti-Rosei profile image

    Enrico Agabiti-Rosei ESH Representative

    Italy

    more

Awards Committee

The Society offers a number of awards and prizes at each Biennial Scientific Meeting to support basic, clinical and scientific research work into the causes, treatment and prevention of hypertension and associated cardiovascular diseases. A list of the current ISH awards and prizes, and past winners, can be viewed on the ISH website.

The Awards Committee reports to the Executive Committee and is responsible for (1) soliciting nominations for the awards from ISH members; (2) making recommendations and assist with the selection of awards to individuals, groups or institutions honoured by the Society and with the selection of Distinguished and Honorary Fellows and (3) assessing applications equally on their merits and eligibility.

  • George Stergiou profile image

    George Stergiou Chair

    Greece

    more

  • John Chalmers profile image

    John Chalmers

    Australia

    more

  • Tony Heagerty profile image

    Tony Heagerty

    UK

    more

  • Sadayoshi Ito profile image

    Sadayoshi Ito

    Japan

    more

    My areas of research are the renin-angiotensin-aldosterone system and glomerular hemodynamics in basic research, and hemodynamics in hypertension, secondary hypertension and chronic kidney disease in clinical research.

  • Nadia Khan profile image

    Nadia Khan

    Canada

    more

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

  • Ruan Kruger profile image

    Ruan Kruger

    South Africa

    more

    I am a basic scientist with special interest in clinical and epidemiological population studies focusing on ethnic phenotyping of cardiovascular pathophysiology related to hypertension, arterial stiffness and cardiac impairment (echocardiography). My research particularly includes novel biomarkers and early predictors of cardiovascular disease aiming to contribute to the prevention of early incidence in sub-Saharan Africa.

  • Neil Poulter profile image

    Neil Poulter

    UK

    more

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Alta Schutte profile image

    Alta Schutte

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Maciej Tomaszewski profile image

    Maciej Tomaszewski

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

Board of Management of the Journal of Hypertension

The Journal of Hypertension is the official Journal of the ISH and European Society of Hypertension (ESH). In addition to primary papers from world-renowned experts, the Journal contains authoritative reviews that summarise and evaluate the most significant recent developments. Also included are special reports, original short papers containing innovative and time-sensitive information.

The Board of Management of the journal membership is a joint body of the Society and the ESH, with representation from the Publishers of the Journal. Members nominated by ISH are as listed below.

  • Lewis Landsberg profile image

    Lewis Landsberg Chair

    USA

    more

    Areas of interest in relation to blood pressure:

    • Sympathetic nervous system
    • Obesity-related hypertension
    • The metabolic syndrome
  • Fadi Charchar profile image

    Fadi Charchar

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Lars H. Lindholm profile image

    Lars H. Lindholm

    Sweden

    more

    I have been President of the Swedish Society of Hypertension (1989-92), Secretary (the first) of the European Society of Hypertension, ESH (1989-97) , and President of the ISH (2006-8). Since 2009, I have been an honorary member of the British Society of Hypertension.

    My interest in hypertension and its risks started in the late 1970s and I defended my doctoral thesis on this topic in 1994. Since 1998, I am Professor and chairman at the Department of Public Health and Clinical Medicine at Umeå University, Sweden.

  • Maciej Tomaszewski profile image

    Maciej Tomaszewski

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

Communications Committee

The Communications Committee has responsibility for the production of the Society newsletter, the monthly e-Bulletin, all Society print and promotional material and the development and maintenance of the website at an editorial level. This Committee must ensure the correct use of the Society logos and provide direction for social media activities and other new methods of communication with members. The Communications Committee reports to, and advises, the Executive Committee on the communications strategy for the Society.

  • Dylan Burger profile image

    Dylan Burger Chair and Deputy Editor of the Hypertension News Sub-Committee

    Canada

    more

    My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

  • Anastasia Mihailidou profile image

    Anastasia Mihailidou

    Australia

  • Richard Wainford profile image

    Richard Wainford

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

Hypertension News Sub-committee

  • Lars H. Lindholm profile image

    Lars H. Lindholm Chair and Editor

    Sweden

    more

    I have been President of the Swedish Society of Hypertension (1989-92), Secretary (the first) of the European Society of Hypertension, ESH (1989-97) , and President of the ISH (2006-8). Since 2009, I have been an honorary member of the British Society of Hypertension.

    My interest in hypertension and its risks started in the late 1970s and I defended my doctoral thesis on this topic in 1994. Since 1998, I am Professor and chairman at the Department of Public Health and Clinical Medicine at Umeå University, Sweden.

  • Dylan Burger profile image

    Dylan Burger Deputy Editor

    Canada

    more

    My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

  • Tony Heagerty profile image

    Tony Heagerty

    UK

    more

  • Thomas Kahan profile image

    Thomas Kahan

    Sweden

    more

    I am professor of medicine at Karolinska Institutet, Stockholm and serve as a senior consultant in cardiology at Danderyd University Hospital, Stockholm, where I am head of the Unit for Cardiovascular Risk Assessment. My main research areas are neurohormonal mechanisms in the control of blood pressure and cardiac function, with a focus on structural myocardial and vascular changes, and neuroendocrine mechanisms in heart failure. Other areas of interest are cardiovascular risk assessment and prevention.

  • Thomas Unger profile image

    Thomas Unger

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

Corporate Liaison Committee

The Corporate Liaison Committee reports to the Executive Committee and is charged with maintaining constructive relations with the corporate sector. Industry supporters can include pharmaceutical companies, device manufacturers and organisations with an interest in hypertension and cardiovascular research. For example, these could include representatives of the food industry or companies producing tele-medical devices (used for remote care and collection of data in remote locations in both developed and less developed countries).

  • Markus Schlaich profile image

    Markus Schlaich Chair

    Australia

    more

    I am the Dobney Chair in Clinical Research at the University of Western Australia, based at the Royal Perth Hospital. As a clinician-scientist and renal physician I have specific interest in hypertension associated with chronic kidney disease and the role of the sympathetic nervous system in this scenario. My major aim is to translate evidence from mechanistic studies into clinical practice to improve outcomes for patients with hypertension and associated co-morbidities.

  • Sadayoshi Ito profile image

    Sadayoshi Ito Deputy Chair

    Japan

    more

    My areas of research are the renin-angiotensin-aldosterone system and glomerular hemodynamics in basic research, and hemodynamics in hypertension, secondary hypertension and chronic kidney disease in clinical research.

  • Sofie Brouwers profile image

    Sofie Brouwers

    Switzerland

    more

    As a clinician-scientist, I conduct therapeutic research along with my clinical work. My basic research activities focus on the pathophysiology of hypertension, with special interest for the role of the renin angiotensin system and the central nervous system in the long-term regulation of blood pressure.

  • Dorairaj Prabhakaran profile image

    Dorairaj Prabhakaran

    India

    more

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence, Centre for Cardio-metabolic Risk Reduction in South Asia (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

  • Thomas Unger profile image

    Thomas Unger

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

ISH International Forum

The International Forum of the ISH embodies and nurtures the global nature of the ISH and was first established in 1992. It is a consultative forum, the mandate of which is to establish effective liaison between the ISH and National and Regional Societies of Hypertension or Councils of High Blood Pressure Research (known as Affiliated Societies). It also provides a unique infrastructure and platform for networking and “cross-talk” between Societies. Presidents of ISH Affiliated Societies, or their representaties, are invited to attend a Society meeting at the time of the ISH Biennial Scientific Meetings. ISH International Forum Officers report to the Executive Committee of the Society.

View a list of ISH Affiliated Societies.

  • Neil Poulter profile image

    Neil Poulter Chair

    UK

    more

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

Membership Committee

The Membership Committee advises the Council on the election of members or fellows from all categories of membership (Professional Member, Emerging Leader, Research Fellow and Emeritus Fellow) and on the exemption from fees for Professional Members from countries with economic hardship.

  • Richard Wainford profile image

    Richard Wainford Chair

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

  • Claudio Borghi profile image

    Claudio Borghi

    Italy

    more

    My main areas of interest are the hypertension and related cardiovascular risk factors and drug therapy of hypertensive disease. In particular I am very interested in the interactions between hypertensive disease and metabolic risk factors paying a special attention to epidemiology, pathophysiology and drug treatment including the options supporting the use of different preventive approaches in patients with complex CV risk profile. I am also involved in the development of a nutraceutical approach to the management of hypertension and related risk factors.

  • Sofie Brouwers profile image

    Sofie Brouwers

    Switzerland

    more

    As a clinician-scientist, I conduct therapeutic research along with my clinical work. My basic research activities focus on the pathophysiology of hypertension, with special interest for the role of the renin angiotensin system and the central nervous system in the long-term regulation of blood pressure.

  • Rafael Castillo profile image

    Rafael Castillo

    Philippines

    more

    As a senior clinical cardiologist at the Manila Doctor’s Hospital and a pioneering faculty member at the Adventist University College of Medicine, I’m part of a group involved in clinical trials evaluating drug and non-drug interventions in the management of high-risk hypertensive patients with various comorbidities. I’m a past president of the Asian Pacific Society of Hypertension, Philippine Heart Association/Philippine College of Cardiology, Philippine Society of Hypertension; and past chair of the Philippine Specialty Board of Adult Cardiology.

  • Fady Hannah-Shmouni profile image

    Fady Hannah-Shmouni

    USA

  • Nadia Khan profile image

    Nadia Khan

    Canada

    more

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

  • Yoshihiro Kokubo profile image

    Yoshihiro Kokubo

    Japan

    more

    I am a chief doctor in the National Cerebral and Cardiovascular Center, Japan. My specialty is preventive medicine and epidemiology, especially related to hypertension and kidney dysfunction. I contribute to many international societies in variety of capacities and editorial board activities in the areas of hypertension, stroke, and preventive medicine.

  • Agustin Ramirez profile image

    Agustin Ramirez

    Argentina

    more

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Elena Velkoska profile image

    Elena Velkoska

    Australia

Mentorship and Training Committee

  • Fadi Charchar profile image

    Fadi Charchar Chair

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Krasimira Hristova profile image

    Krasimira Hristova

    Bulgaria

    more

    I am a specialist cardiologist, expert of echocardiography, at University National Heart Hospital, Sofia, Bulgaria and consulting cardiologist at “Nadezhda” Hospital, Sofia, Bulgaria. My main research interests are the carotid blood flow and cardiac function in patients with cerebrovascular diseases, hypertension in women an in pregnancy.

  • Vanja Ivkovic profile image

    Vanja Ivkovic

    Croatia

  • Yoshihiro Kokubo profile image

    Yoshihiro Kokubo

    Japan

    more

    I am a chief doctor in the National Cerebral and Cardiovascular Center, Japan. My specialty is preventive medicine and epidemiology, especially related to hypertension and kidney dysfunction. I contribute to many international societies in variety of capacities and editorial board activities in the areas of hypertension, stroke, and preventive medicine.

  • Jolanta Malyszko profile image

    Jolanta Malyszko

    Poland

    more

    My major interest is hypertension in patients with kidney disease and those on renal replacement therapy (dialysis, transplantation), diabetic kidney disease, cardiovascular complications as well as endothelial dysfunction in nephrology.

  • Francine Marques profile image

    Francine Marques

    Australia

    more

    My research focuses on the molecular mechanisms leading to hypertension, in particular those involving microRNAs and the gut microbiota. My aim is to combine models of disease with human studies to facilitate translation of research and decrease the burden of hypertension.

  • Anastasia Mihailidou profile image

    Anastasia Mihailidou

    Australia

  • Richard Wainford profile image

    Richard Wainford

    USA

    more

    My research interests are focused on understanding the pathophysiology of hypertension, with particular regard to central neural control of the kidney and the implications of this for long-term blood pressure regulation. As such my research is focused on the areas of: Renal Sodium Handling, Neural Control of Blood Pressure, Salt-Sensitive Hypertension.

New Investigator Committee

The New Investigator Committee (NIC) is charged with encouraging and supporting initiatives to attract and retain younger members of the ISH and reports to the Executive Committee of the Society.

The ISH New Investigator Network (ISHNIN) serves as a platform for interaction between students and new investigators and allows new avenues for communication, collaboration and education. The network provides opportunities for all new scientists within the ISH to interact and build relationships, as well as to gain experience and exposure within the Society as they start their scientific careers. The network is run by the committee and mains a presence on the ISH website and social media platforms including Facebook, LinkedIn, Twitter and YouTube.

Go to the ISH New Investigator Network.

Click here to view a list of the New Investigator Committee Members

Past Presidents

  • IH Page USA 1966-1970
  • F Gross Germany 1970-1976
  • JIS Robertson UK 1976-1978
  • A Zanchetti Italy 1978-1980
  • JO Davis USA 1980-1982
  • AE Doyle Australia 1982-1984
  • L Hansson Sweden 1984-1986
  • JH Laragh USA 1986-1988
  • G Mancia Italy 1988-1990
  • PA van Zwieten The Netherlands 1990-1992
  • JP Chalmers Australia 1992-1994
  • K Arakawa Japan 1994-1996
  • JN Cohn USA 1996-1998
  • K-H Rahn Germany 1998-2000
  • A Mimran France 2000-2002
  • LJ Beilin Australia 2002-2004
  • MH Alderman USA 2004-2006
  • LH Lindholm Sweden 2006-2008
  • AM Heagerty UK 2008-2010
  • Stephen Harrap Australia 2010-2012
  • Ernesto Schiffrin Canada 2012-2014
  • Rhian Touyz UK 2014-2016
  • Neil Poulter UK 2016-2018

Regional Advisory Groups (RAGs)

The purpose of the Regional Advisory Groups (RAGs) is to provide comprehensive Society representation globally, to distil regional issues and encourage and enhance education and biomedical research in the fields of hypertension and associated cardiovascular diseases.

ISH has created RAGs for (1) Africa (2) Asia and Australasia (3) Central and South America (4) Eastern Europe and Middle East (5) Western Europe and North America. Each RAG reports to the Executive Committee of the Society.

Africa RAG

  • Albertino Damasceno profile image

    Albertino Damasceno Chair

    Mozambique

    Areas of interest:

    • Epidemiology of Hypertension and risk factors
    • Stroke
    • Salt and Hypertension
    • 24 H monitoring of the Blood Pressure

Americas RAG

  • Agustin Ramirez profile image

    Agustin Ramirez Co-Chair (Central and South America)

    Argentina

    Areas related to hypertension: Renal Sodium Handling, Autonomic Nervous System and Blood Pressure Control, metabolic Syndrome and Hypertension.

  • Nadia Khan profile image

    Nadia Khan Co-Chair (North America)

    Canada

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

Europe RAG

  • Peter Nilsson profile image

    Peter Nilsson Chair

    Sweden

    My main area of expertise is cardiovascular and metabolic risk mechanisms. This is especially relevant for studies related to the Early Vascular Aging (EVA) syndrome – a cardiovascular risk syndrome based mainly on the combination of increased arterial stiffness (pulse wave velocity), impaired glucose metabolism, telomere length shortening, and early signs of atherosclerosis (intima media thickness in art. carotis). Another field of interest is the gene-environment interactions behind the development of obesity and type 2 diabetes, but also the study of patients with type 1 diabetes of long duration but escaping major complications (PROLONG study).

North Asia, South-East Asia and Oceania RA

  • Markus Schlaich profile image

    Markus Schlaich Co-Chair

    Australia

    I am the Dobney Chair in Clinical Research at the University of Western Australia, based at the Royal Perth Hospital. As a clinician-scientist and renal physician I have specific interest in hypertension associated with chronic kidney disease and the role of the sympathetic nervous system in this scenario. My major aim is to translate evidence from mechanistic studies into clinical practice to improve outcomes for patients with hypertension and associated co-morbidities.

  • Yoshihiro Kokubo profile image

    Yoshihiro Kokubo Co-Chair

    Japan

    I am a chief doctor in the National Cerebral and Cardiovascular Center, Japan. My specialty is preventive medicine and epidemiology, especially related to hypertension and kidney dysfunction. I contribute to many international societies in variety of capacities and editorial board activities in the areas of hypertension, stroke, and preventive medicine.

South and West Asia and The Middle East RAG

  • Dorairaj Prabhakaran profile image

    Dorairaj Prabhakaran Chair

    India

    I am a cardiologist and epidemiologist and currently the Executive Director of Initiative for Cardiovascular Health in Developing Countries (ICHEALTH) and Director Centre of Excellence, Centre for Cardio-metabolic Risk Reduction in South Asia (strategic grant funded by the National Institutes of Health and United Health group) at the Public Health Foundation of India.

Research, Science and Education Committee

  • Claudio Borghi profile image

    Claudio Borghi Chair

    Italy

    more

    My main areas of interest are the hypertension and related cardiovascular risk factors and drug therapy of hypertensive disease. In particular I am very interested in the interactions between hypertensive disease and metabolic risk factors paying a special attention to epidemiology, pathophysiology and drug treatment including the options supporting the use of different preventive approaches in patients with complex CV risk profile. I am also involved in the development of a nutraceutical approach to the management of hypertension and related risk factors.

  • Fadi Charchar profile image

    Fadi Charchar

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Neil Poulter profile image

    Neil Poulter

    UK

    more

    My main areas of interest in relation to blood pressure are investigating evaluating the optimisation of blood pressure measurement and control and to ensure maximal prevention of cardiovascular diseases in hypertensive patients from all the major ethnic groups.

  • Alta Schutte profile image

    Alta Schutte

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Maciej Tomaszewski profile image

    Maciej Tomaszewski

    UK

    more

    My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

    I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

  • Thomas Unger profile image

    Thomas Unger

    Netherlands

    more

    My research interest has been focused on peptidergig systems, in particular the Renin-Angiotensin system (RAS) and its CNS-related and peripheral role in the pathophysiology of cardiovascular diseases. As a basic and clinical pharmacologist, I have performed numerous pre-clinical studies and participated in clinical trials investigating the therapeutic aspects of modulating the RAS in hypertension and related diseases, and I have contributed to the development of several RAS modulating drugs.

Women in Hypertension Committee

  • Muscha (Ulrike) Steckelings profile image

    Muscha (Ulrike) Steckelings Chair

    Denmark

    more

    My research interests lie in the protective arm of the renin angiotensin system, in particular the angiotensin AT2-receptor and the receptor MAS, spanning from the basic biology of these receptors over pre-clinical studies to test their therapeutic efficacy in cardiovascular (e.g. heart failure, hypertensive and diabetic end organ damage, stroke) and other diseases to the involvement in the development of AT2-recepor agonists for future clinical use.

  • Sofie Brouwers profile image

    Sofie Brouwers

    Switzerland

    more

    As a clinician-scientist, I conduct therapeutic research along with my clinical work. My basic research activities focus on the pathophysiology of hypertension, with special interest for the role of the renin angiotensin system and the central nervous system in the long-term regulation of blood pressure.

  • Louise Burrell profile image

    Louise Burrell

    Australia

    more

    My research interests include the pathophysiology of hypertension, with particular regard to the renin angiotensin system; diabetic heart disease and the role of echocardiography; and novel biomarkers in coronary artery disease.

  • Fadi Charchar profile image

    Fadi Charchar

    Australia

    more

    My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

  • Nadia Khan profile image

    Nadia Khan

    Canada

    more

    I am a clinician scientist in epidemiology and health services research. My research area is focused on ethnic and sex differences in hypertension and cardiovascular disease chronic disease management.

  • Alta Schutte profile image

    Alta Schutte

    South Africa

    more

    As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

  • Rhian Touyz profile image

    Rhian Touyz

    UK

    more

    I am the British Heart Foundation Chair in Cardiovascular Medicine, based in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.

    I am a clinician-scientist investigating the molecular and cellular mechanisms of hypertension. I am committed to hypertension through clinical and basic research, clinical service, teaching, mentoring and leadership and to establishing international networks for trainees and new investigators in hypertension research.

Join ISH in 3 simple steps...Apply Now

Latest Tweets:

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.